心血管健康、勃起功能障碍与睾酮替代治疗:争议与相关性
本文综述心血管疾病、勃起功能障碍与睾酮替代治疗三者关系。性腺功能减退是心血管事件和死亡风险因素,但至少4项近期报告提示睾酮替代可能加重心血管风险,增加临床治疗顾虑。文章为医生应对这些担忧提供指导原则。
要点
- 勃起功能障碍与心血管疾病共享相似病理生理基础,低血清睾酮(性腺功能减退)在两者中均起重要作用。
- 性腺功能减退是心血管事件和死亡恶化的已知风险因素,促使医生推荐睾酮替代治疗。
- 至少4项近期报告提示睾酮替代可能加重心血管风险,增加医疗界治疗性腺功能减退患者的犹豫。
核心结论
- 本文强调心血管疾病、勃起功能障碍与睾酮治疗三者关联,并为医生应对近期担忧提供指导原则。
主要发现
- 勃起功能障碍与心血管疾病共享相似病理生理基础,低血清睾酮(性腺功能减退)是两者中的重要因素。
- 性腺功能减退是心血管事件和死亡恶化的已知风险因素。
- 至少4项近期报告提示睾酮替代可能加重心血管风险,增加医疗界治疗性腺功能减退患者的犹豫。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Erectile dysfunction and cardiovascular disease share a similar underlying pathophysiology, and low serum testosterone, known as hypogonadism, is a significant player in both conditions. Hypogonadism is a known risk factor for cardiovascular events and worsened mortality, thus influencing physicians to recommend testosterone replacement in hypogonadal men. However, at least 4 recent reports suggest that testosterone replacement may worsen cardiovascular risk, heightening hesitancy in the medical community to treat patients with hypogonadism with testosterone. This review highlights the triad of cardiovascular disease, erectile dysfunction, and testosterone therapy and provides the physician with some guiding principles for navigating these recent concerns.
引用
- Elkhoury FF, Rambhatla A, Mills JN, et al. Cardiovascular Health, Erectile Dysfunction, and Testosterone Replacement: Controversies and Correlations. Urology. 2017. PMID: 28774772. doi:10.1016/j.urology.2017.07.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。